Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK market set to lose major stock as BHP plans Australia shift

Tue, 17th Aug 2021 15:35

By Joice Alves

LONDON, Aug 17 (Reuters) - London's FTSE 100 index will lose
its second largest company by market capitalisation if
shareholders back plans by global resource giant BHP Group
to end its dual listing structure and make
Australia its primary stock market.

BHP has previously come under pressure from some
shareholders, notably activist investor Elliott Advisors, to
simplify its structure, but had said any gains would be less
than the cost of change.

Now the discount of London-listed stocks is at its deepest
in more than three decades, BHP, which on Tuesday reported its
best annual profit in nearly a decade, said it planned to get
rid of its London listing.

Shareholders are expected to vote on the unification at
meetings in the first half of 2022.

If the plan gets board and shareholder approval, the London
Stock Exchange will lose a major player. BHP has 128 billion
pounds ($176.22 billion) in market cap, second only to
AstraZeneca with around 131 billion pounds, Refinitiv
data shows.

BHP is the biggest company by market capitalisation on the
Australian stock exchange.

The value of British stocks versus global peers has been
depressed by the combined impact of Britain's departure from the
European Union, a weak pound and a lack of tech stocks, which
have been the big beneficiaries of the disruption caused by the
pandemic.

London-listed shares are trading at 12.6 times
forward earnings, that compares to 17.3 times for the Australian
benchmark.

Following news of the plan to end the London listing, BHP's
London shares rose 6% by 1352 GMT, outperforming the wider
market.

Jamie Maddock, equity research analyst at Quilter Cheviot,
said BHP's departure is bad news for UK-focused investors as
country index trackers would be forced to sell their shares. The
move would also reduce significantly London's exposure to the
mining sector.

David Madden, market analyst at Equiti Capital in London
said the London stock market would still be attractive and noted
it has attracted a surge of initial public offerings this year.

"The London Stock Exchange’s deep liquidity pool will ensure
it remains popular for listings", he said.

Last year, consumer brands company Unilever, which
like BHP had a dual-listing, merged its Dutch and British
corporate entities and Unilever NV's Amsterdam-listed shares
ceased trading.

($1 = 0.7264 pounds)

(Reporting by Joice Alves; editing by Barbara Lewis)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.